help button home button Am J Pathol ASIP MEMBERSHIP
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Groves, C.
Right arrow Articles by Tomlinson, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Groves, C.
Right arrow Articles by Tomlinson, I.
(American Journal of Pathology. 2002;160:2055-2061.)
© 2002 American Society for Investigative Pathology

Regular Articles

Mutation Cluster Region, Association Between Germline and Somatic Mutations and Genotype-Phenotype Correlation in Upper Gastrointestinal Familial Adenomatous Polyposis

Christopher Groves*, Hanan Lamlum{dagger}, Michael Crabtree*{dagger}, Jill Williamson{ddagger}, Claire Taylor§, Sylvia Bass§, Darren Cuthbert-Heavens§, Shirley Hodgson, Robin Phillips* and Ian Tomlinson{dagger}

From the Academic Unit and Polyposis Registry,*Saint Mark’s Hospital, Harrow; the Molecular and Population Genetics Laboratory{dagger}and the Human Cytogenetics Laboratory,{ddagger}Cancer Research United Kingdom, London; the Mutation Detection Laboratory,§Cancer Research United Kingdom, Saint James’s University Hospital, Leeds; and the Department of Clinical Genetics,Cancer Research United Kingdom, Guy’s Hospital, London, United Kingdom

Studies of adenomatous polyposis coli (APC) mutations in familial adenomatous polyposis (FAP) have focused on large bowel disease. It has been found that: 1) germline APC mutations around codon 1300 are associated with severe colorectal polyposis; 2) somatic APC mutations in colorectal tumors tend to cluster approximately between codons 1250 and 1450; and 3) patients with germline mutations close to codon 1300 tend to acquire somatic mutations (second hits) in their colorectal polyps by allelic loss, whereas the tumors of other FAP patients have truncating second hits. Using new and published data, we have investigated how germline and somatic APC mutations influence the pathogenesis of upper gastrointestinal polyps in FAP. We have compared the results with those from colorectal disease. We found that somatic mutations in upper gastrointestinal polyps cluster approximately between codons 1400 and 1580. Patients with germline APC mutations after codon 1400 tend to show allelic loss in their upper gastrointestinal polyps; the tumors of other patients have truncating somatic mutations after codon 1400. Finally, patients with germline mutations after codon 1400 tend to have more severe duodenal polyposis (odds ratio, 5.72; 95% confidence interval, 1.13 to 28.89; P = 0.035). Thus, in both upper gastrointestinal and colorectal tumors, a specific region of the APC gene is associated with severe disease, clustering of somatic mutations, and loss of the wild-type allele. However, the region concerned is different in upper gastrointestinal and colorectal disease. The data suggest that loss of all APC SAMP repeats is probably necessary for duodenal and gastric tumorigenesis in FAP, as it is in colonic tumors. Compared with colonic tumors, however, retention of a greater number of ß-catenin binding/degradation repeats is optimal for tumorigenesis in upper gastrointestinal FAP.




This article has been cited by other articles:


Home page
 Hum Mol GenetHome page
E. M. Kohler, S. H. V. Chandra, J. Behrens, and J. Schneikert
{beta}-Catenin degradation mediated by the CID domain of APC provides a model for the selection of APC mutations in colorectal, desmoid and duodenal tumours
Hum. Mol. Genet., January 15, 2009; 18(2): 213 - 226.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
A. Milicic, L.-A. Harrison, R. A. Goodlad, R. G. Hardy, A. M. Nicholson, M. Presz, O. Sieber, S. Santander, J. H. Pringle, N. Mandir, et al.
Ectopic Expression of P-Cadherin Correlates with Promoter Hypomethylation Early in Colorectal Carcinogenesis and Enhanced Intestinal Crypt Fission In vivo
Cancer Res., October 1, 2008; 68(19): 7760 - 7768.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
E. S. Ong, M. A. Alassas, P. N. Bogner, K. Bullard Dunn, W. Y. Chey, and J. F. Gibbs
Total Gastrectomy for Gastric Dysplasia in a Patient With Attenuated Familial Adenomatous Polyposis Syndrome
J. Clin. Oncol., July 20, 2008; 26(21): 3641 - 3642.
[Full Text] [PDF]

Home page
 J. Med. Genet.Home page
X. Zhang and A. Chang
Somatic mutations of the epidermal growth factor receptor and non-small-cell lung cancer
J. Med. Genet., March 1, 2007; 44(3): 166 - 172.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
A. Latchford, E. Volikos, V. Johnson, P. Rogers, N. Suraweera, I. Tomlinson, R. Phillips, and A. Silver
APC mutations in FAP-associated desmoid tumours are non-random but not 'just right'
Hum. Mol. Genet., January 1, 2007; 16(1): 78 - 82.
[Abstract] [Full Text] [PDF]

Home page
 Jpn J Clin OncolHome page
M. Mutoh, T. Akasu, M. Takahashi, N. Niho, T. Yoshida, T. Sugimura, and K. Wakabayashi
Possible Involvement of Hyperlipidemia in Increasing Risk of Colorectal Tumor Development in Human Familial Adenomatous Polyposis
Jpn. J. Clin. Oncol., March 1, 2006; 36(3): 166 - 171.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
L A A Brosens, J J Keller, G J A Offerhaus, M Goggins, and F M Giardiello
Prevention and management of duodenal polyps in familial adenomatous polyposis
Gut, July 1, 2005; 54(7): 1034 - 1043.
[Full Text] [PDF]

Home page
 GutHome page
N J H Sturt, M C Gallagher, P Bassett, C R Philp, K F Neale, I P M Tomlinson, A R J Silver, and R K S Phillips
Evidence for genetic predisposition to desmoid tumours in familial adenomatous polyposis independent of the germline APC mutation
Gut, December 1, 2004; 53(12): 1832 - 1836.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
Z. Kemp, C. Thirlwell, O. Sieber, A. Silver, and I. Tomlinson
An update on the genetics of colorectal cancer
Hum. Mol. Genet., October 1, 2004; 13(suppl_2): R177 - R185.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
S Bulow, J Bjork, I J Christensen, O Fausa, H Jarvinen, F Moesgaard, and H F A Vasen
Duodenal adenomatosis in familial adenomatous polyposis
Gut, March 1, 2004; 53(3): 381 - 386.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
M L Bisgaard, R Ripa, A L Knudsen, and S Bulow
Familial adenomatous polyposis patients without an identified APC germline mutation have a severe phenotype
Gut, February 1, 2004; 53(2): 266 - 270.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
C. Doglioni, S. Piccinin, S. Demontis, M. G. Cangi, L. Pecciarini, C. Chiarelli, M. Armellin, T. Vukosavljevic, M. Boiocchi, and R. Maestro
Alterations of {beta}-Catenin Pathway in Non-Melanoma Skin Tumors: Loss of {alpha}-ABC Nuclear Reactivity Correlates with the Presence of {beta}-Catenin Gene Mutation
Am. J. Pathol., December 1, 2003; 163(6): 2277 - 2287.
[Abstract] [Full Text]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
W. R. Bruce
Counterpoint: From Animal Models to Prevention of Colon Cancer. Criteria for Proceeding from Preclinical Studies and Choice of Models for Prevention Studies
Cancer Epidemiol. Biomarkers Prev., May 1, 2003; 12(5): 401 - 404.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the American Society for Investigative Pathology.